CCN3/NOV serum levels in coronary artery disease (CAD) patients and its correlation with TNF-α and IL-6

被引:6
|
作者
Jaafar, Alaa Fadhil [1 ]
Afrisham, Reza [1 ]
Fadaei, Reza [2 ,3 ]
Farrokhi, Vida [4 ]
Moradi, Nariman [5 ]
Abbasi, Ali [6 ]
Einollahi, Nahid [1 ]
机构
[1] Univ Tehran Med Sci, Sch Allied Med Sci, Dept Clin Lab Sci, Tehran, Iran
[2] Kermanshah Univ Med Sci, Sleep Disorders Res Ctr, Kermanshah, Iran
[3] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA
[4] Univ Tehran Med Sci, Fac Allied Med, Dept Hematol, Tehran, Iran
[5] Kurdistan Univ Med Sci, Res Inst Hlth Dev, Liver & Digest Res Ctr, Sanandaj, Iran
[6] Univ Tehran Med Sci, Dr Shariatee Training & Res Hosp, Dept Cardiol, Tehran, Iran
关键词
NOV/CCN3; Coronary artery disease; Inflammatory cytokines; Insulin resistance; Obesity; CCN FAMILY; NOV CCN3; EXPRESSION; NOV/CCN3; GENES; OBESITY;
D O I
10.1186/s13104-023-06590-x
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction Dysregulation in the secretion of adipokines or adipocytokines plays a significant role in triggering a pro-inflammatory state, leading to endothelial dysfunction and insulin resistance, and ultimately elevating the risk of atherosclerosis and coronary artery disease (CAD). Previous studies have shown a link between NOV/CCN3 (an adipokine) and obesity, insulin resistance, and inflammation. However, no research has explored the relationship between CCN3 serum levels and CAD. Therefore, we conducted the first investigation to examine the correlation between CCN3 and CAD risk factors in patients.Methods In a case-control study, we measured the serum levels of CCN3, IL-6, adiponectin, and TNF-alpha in 88 angiography-confirmed CAD patients and 88 control individuals using ELISA kits. Additionally, we used an auto analyzer and commercial kits to measure the biochemical parameters.Results In patients with CAD, the serum levels of CCN3, TNF-alpha, and IL-6 were significantly higher compared to the control group, whereas lower levels of adiponectin were observed in the CAD group (P < 0.0001). A positive correlation was found between CCN3 and IL-6 and TNF-alpha in the CAD group ([r = 0.38, P < 0.0001], [r = 0.39, P < 0.0001], respectively). A binary logistic regression analysis showed the risk of CAD in the model adjusted (OR [95% CI] = 1.29 [1.19 - 1.41]), (P < 0.0001). We determined a cut-off value of CCN3 (3169.6 pg/mL) to distinguish CAD patients from the control group, with good sensitivity and specificity obtained for this finding (83.8% and 87.5%, respectively).Conclusion This study provides evidence of a positive association between CCN3 serum levels and CAD, as well as inflammation markers such as IL-6 and TNF-alpha. These findings suggest that CCN3 may serve as a potential biomarker for CAD, and further investigations are necessary to validate this association and explore its potential use in clinical settings.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] CCN3/NOV serum levels in coronary artery disease (CAD) patients and its correlation with TNF-α and IL-6
    Alaa Fadhil Jaafar
    Reza Afrisham
    Reza Fadaei
    Vida Farrokhi
    Nariman Moradi
    Ali Abbasi
    Nahid Einollahi
    BMC Research Notes, 16
  • [2] CCN3/NOV Serum Levels in Non-alcoholic Fatty Liver Disease (NAFLD) Patients in Comparison with the Healthy Group and its Correlation with TNF-α and IL-6
    Afrisham, Reza
    Alasvand, Ghazal
    Jadidi, Yasaman
    Farrokhi, Vida
    Moradi, Nariman
    Alizadeh, Shaban
    Fadaei, Reza
    CURRENT MOLECULAR MEDICINE, 2024,
  • [3] Serum levels of IL-32 in patients with coronary artery disease and its relationship with the serum levels of IL-6 and TNF-α
    Mohammad-Rezaei, Mina
    Ahmadi, Reza
    Rafiei, Ali
    Khaledifar, Arsalan
    Fattahi, Soheila
    Samiei-Sefat, Azadeh
    Emami, Shohreh
    Bagheri, Nader
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (05) : 4263 - 4271
  • [4] Serum levels of IL-32 in patients with coronary artery disease and its relationship with the serum levels of IL-6 and TNF-α
    Mina Mohammad-Rezaei
    Reza Ahmadi
    Ali Rafiei
    Arsalan Khaledifar
    Soheila Fattahi
    Azadeh Samiei-Sefat
    Shohreh Emami
    Nader Bagheri
    Molecular Biology Reports, 2021, 48 : 4263 - 4271
  • [5] The Serum Levels of IL-36 in Patients with Coronary Artery Disease and Their Correlation with the Serum Levels of IL-32, IL-6, TNF-a, and Oxidative Stress
    Kazemian, Shakiba
    Ahmadi, Reza
    Rafiei, Ali
    Azadegan-Dehkordi, Fatemeh
    Khaledifar, Arsalan
    Abdollahpour-Alitappeh, Meghdad
    Bagheri, Nader
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2022, 183 (10) : 1137 - 1145
  • [6] Circulating levels of C1q/TNF-α-related protein 6 (CTRP6) in coronary artery disease and its correlation with inflammatory markers
    Tabatabaei, Seyed abdolhossein
    Fadaei, Reza
    Moradi, Nariman
    Farrokhi, Vida
    Vatannejad, Akram
    Afrisham, Reza
    Falahat, Arash
    Malekshahi, Frood
    Mirahmad, Maryam
    Abbasi, Ali
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2024, 23 (01) : 1233 - 1241
  • [7] Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6
    Fadaei, Reza
    Bagheri, Nader
    Heidarian, Esfandiar
    Nouri, Ali
    Hesari, Zahra
    Moradi, Nariman
    Ahmadi, Alireza
    Ahmadi, Reza
    CYTOKINE, 2020, 125
  • [8] Effects of Adiponectin in TNF-α, IL-6, and IL-10 Cytokine Production from Coronary Artery Disease Macrophages
    Kyriazi, E.
    Tsiotra, P. C.
    Boutati, E.
    Ikonomidis, I.
    Fountoulaki, K.
    Maratou, E.
    Lekakis, J.
    Dimitriadis, G.
    Kremastinos, D. T.
    Raptis, S. A.
    HORMONE AND METABOLIC RESEARCH, 2011, 43 (08) : 537 - 544
  • [9] IL-1β, TNF-α, and IL-6 levels in gingival fluid and serum of patients with ischemic stroke
    Wytrykowska, Anna
    Prosba-Mackiewicz, Maria
    Nyka, Walenty M.
    JOURNAL OF ORAL SCIENCE, 2016, 58 (04) : 509 - 513
  • [10] Association of Promoter Methylation and Expression of Inflammatory Genes IL-6 and TNF-α with the Risk of Coronary Artery Disease in Diabetic and Obese Subjects among Asian Indians
    Indumathi, Bobbala
    Oruganti, Sai Satish
    Sreenu, Boddupally
    Kutala, Vijay Kumar
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2022, 37 (01) : 29 - 39